abicipar pegol: Clinical Trials

8 trials of abicipar pegol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 4 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 12Completed 2
Phase 32Completed 2

Follow abicipar pegol: new trials by email Literature Review of abicipar pegol trials Research Report on abicipar pegol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)
Abicipar pegol - Macular Degeneration
Phase 2CompletedAllergan1242018-05-252020-08-03
Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD
Abicipar pegol - Macular Degeneration
Phase 1CompletedAllergan112017-11-282018-11-01
Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD
Abicipar pegol - Macular Degeneration
Phase 1CompletedAllergan302016-12-072018-02-08
Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
Abicipar Pegol, Ranibizumab, Sham Procedure - Macular Degeneration
Phase 3CompletedAllergan9492015-06-252020-07-30
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
Abicipar Pegol, Ranibizumab, Sham Procedure - Macular Degeneration
Phase 3CompletedAllergan9392015-06-252020-07-28
A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration
abicipar pegol, ranibizumab, sham procedure - Macular Degeneration
Phase 2CompletedAllergan252014-09-012017-04-25
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
abicipar pegol, ranibizumab, sham procedure - Macular Degeneration
Phase 2CompletedAllergan252014-07-012016-05-17
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
abicipar pegol, ranibizumab, sham procedure - Macular Edema
Phase 2CompletedAllergan1512014-07-012015-07-14

Conditions studied

Macular Degeneration (7)  ·  Macular Edema (1)

Sponsors

Allergan (8)

Countries

United States (6)  ·  Japan (3)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)

Top investigators

Cathy Sutherland (2)  ·  Joanne Li (2)  ·  Joanne Li, MD (1)

NIH funding

2014 (2)